Please enable JavaScript to continue using this application.

Compare $CMPX vs $CNTN | Chartloom

Compare

$CMPX vs $CNTN

Compass Therapeutics Inc. · Canton Strategic Holdings Inc

CMPX

Compass Therapeutics Inc.

CNTN

Canton Strategic Holdings Inc

Compare $CMPX vs $CNTN

Comparing Compass Therapeutics Inc. and Canton Strategic Holdings Inc

CMPXCompass Therapeutics Inc.

CNTNCanton Strategic Holdings Inc

CMPXCompass Therapeutics Inc.

Market cap

$179M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.51x

Rev growth (TTM)

—

YTD performance

-80.8%

52W performance

-74.5%

FCF yield

-31.5%

CNTNCanton Strategic Holdings Inc

Market cap

$163M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-37.6%

52W performance

-33.6%

FCF yield

-97.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CMPX

CNTN

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

CNTN

Canton Strategic Holdings Inc

Market Cap

CMPX$179M

CNTN$163M

Enterprise Value

CMPX$143M

CNTN$125M

Price

CMPX$0.99

CNTN$2.11

P/E Ratio

CMPXN/A

CNTNN/A

P/S Ratio

CMPX0.00x

CNTN108.78x

EV/Sales

CMPX0.00x

CNTN83.88x

EV/EBITDA

CMPX0.00x

CNTN0.00x

P/B Ratio

CMPX0.93x

CNTN0.39x

P/FCF Ratio

CMPXN/A

CNTNN/A

EV/FCF

CMPX-2.54x

CNTN-0.79x

PEG Ratio

CMPXN/A

CNTNN/A

Forward P/E (NTM)

CMPXN/A

CNTNN/A

Forward P/S (NTM)

CMPX1.51x

CNTNN/A

Revenue (TTM)

CMPX$0

CNTN$1M

Revenue Growth (YoY)

CMPXN/A

CNTNN/A

Forward Rev Growth

CMPX397.5%

CNTN0.0%

Gross Margin (TTM)

CMPX0.0%

CNTN0.0%

Operating Margin (TTM)

CMPX0.0%

CNTN0.0%

EBITDA Margin (TTM)

CMPX0.0%

CNTN-1120.1%

Net Margin (TTM)

CMPX0.0%

CNTN-6559.1%

FCF Margin (TTM)

CMPXN/A

CNTN-10651.0%

Net Income (TTM)

CMPX$-30M

CNTN$-98M

FCF (TTM)

CMPX$-56M

CNTN$-159M

EPS (TTM)

CMPX$0.00

CNTN-$0.45

ROE (TTM)

CMPX-2994.0%

CNTN-2954.0%

ROA (TTM)

CMPX-2635.0%

CNTN-2342.0%

ROIC (TTM)

CMPX-2994.0%

CNTN-2953.0%

Cash

CMPX$35M

CNTN$37M

Debt

CMPX$0

CNTN$0

Net Cash/Debt

CMPX$35M

CNTN$37M

Current Ratio (TTM)

CMPX11.22x

CNTN15.70x

Quick Ratio (TTM)

CMPX11.15x

CNTN14.45x

Debt/Equity (TTM)

CMPX0.00x

CNTN0.00x

Debt/Assets (TTM)

CMPX0.0%

CNTN0.0%

Interest Coverage (TTM)

CMPXN/A

CNTNN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

CNTN0.00x

Beta

CMPX1.07

CNTN1.52

52W Performance

CMPX-74.5%

CNTN-33.6%

YTD Performance

CMPX-80.8%

CNTN-37.6%

% from 52W High

CMPX-85.6%

CNTN-69.4%

% from 52W Low

CMPX19.7%

CNTN20.6%

Asset Turnover (TTM)

CMPX0.00x

CNTN0.00x

FCF Yield (TTM)

CMPX-31.5%

CNTN-97.9%

Earnings Yield (TTM)

CMPX-16.8%

CNTN-60.3%

Dividend Yield (TTM)

CMPXN/A

CNTNN/A

Rule of 40

CMPX0.0

CNTN-10,651.0

EV/GP/RG

CMPXN/A

CNTNN/A

Ticker research

View CMPX research View CNTN research

Metric	CMPX Compass Therapeutics Inc.	CNTN Canton Strategic Holdings Inc
Market & Valuation
Market Cap	$179M	$163M
Enterprise Value	$143M	$125M
Price	$0.99	$2.11
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	108.78x
EV/Sales	0.00x	83.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	0.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-0.79x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.5%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1120.1%
Net Margin (TTM)	0.0%	-6559.1%
FCF Margin (TTM)	N/A	-10651.0%
Net Income (TTM)	$-30M	$-98M
FCF (TTM)	$-56M	$-159M
EPS (TTM)	$0.00	-$0.45
ROE (TTM)	-2994.0%	-2954.0%
ROA (TTM)	-2635.0%	-2342.0%
ROIC (TTM)	-2994.0%	-2953.0%
Financial Health
Cash	$35M	$37M
Debt	$0	$0
Net Cash/Debt	$35M	$37M
Current Ratio (TTM)	11.22x	15.70x
Quick Ratio (TTM)	11.15x	14.45x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.52
52W Performance	-74.5%	-33.6%
YTD Performance	-80.8%	-37.6%
% from 52W High	-85.6%	-69.4%
% from 52W Low	19.7%	20.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.5%	-97.9%
Earnings Yield (TTM)	-16.8%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-10,651.0
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View CNTN research

Valuation

P/S Ratio

CMPX

0.00x

CNTN

108.78x

EV/FCF

CMPX

-2.54x

CNTN

-0.79x

Growth & revenue

Forward Revenue Growth

CMPX

397.5%

CNTN

0.0%

Profitability & performance

Gross Margin

CMPX

0.0%

CNTN

0.0%

ROE

CNTN

-2954.0%

CMPX

-2994.0%

FCF Yield %

CMPX

-31.5%

CNTN

-97.9%

52-Week Performance

CNTN

-33.6%

CMPX

-74.5%

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

CNTN

Canton Strategic Holdings Inc

Market Cap

CMPX$179M

CNTN$163M

Enterprise Value

CMPX$143M

CNTN$125M

Price

CMPX$0.99

CNTN$2.11

P/E Ratio

CMPXN/A

CNTNN/A

P/S Ratio

CMPX0.00x

CNTN108.78x

EV/Sales

CMPX0.00x

CNTN83.88x

EV/EBITDA

CMPX0.00x

CNTN0.00x

P/B Ratio

CMPX0.93x

CNTN0.39x

P/FCF Ratio

CMPXN/A

CNTNN/A

EV/FCF

CMPX-2.54x

CNTN-0.79x

PEG Ratio

CMPXN/A

CNTNN/A

Forward P/E (NTM)

CMPXN/A

CNTNN/A

Forward P/S (NTM)

CMPX1.51x

CNTNN/A

Revenue (TTM)

CMPX$0

CNTN$1M

Revenue Growth (YoY)

CMPXN/A

CNTNN/A

Forward Rev Growth

CMPX397.5%

CNTN0.0%

Gross Margin (TTM)

CMPX0.0%

CNTN0.0%

Operating Margin (TTM)

CMPX0.0%

CNTN0.0%

EBITDA Margin (TTM)

CMPX0.0%

CNTN-1120.1%

Net Margin (TTM)

CMPX0.0%

CNTN-6559.1%

FCF Margin (TTM)

CMPXN/A

CNTN-10651.0%

Net Income (TTM)

CMPX$-30M

CNTN$-98M

FCF (TTM)

CMPX$-56M

CNTN$-159M

EPS (TTM)

CMPX$0.00

CNTN-$0.45

ROE (TTM)

CMPX-2994.0%

CNTN-2954.0%

ROA (TTM)

CMPX-2635.0%

CNTN-2342.0%

ROIC (TTM)

CMPX-2994.0%

CNTN-2953.0%

Cash

CMPX$35M

CNTN$37M

Debt

CMPX$0

CNTN$0

Net Cash/Debt

CMPX$35M

CNTN$37M

Current Ratio (TTM)

CMPX11.22x

CNTN15.70x

Quick Ratio (TTM)

CMPX11.15x

CNTN14.45x

Debt/Equity (TTM)

CMPX0.00x

CNTN0.00x

Debt/Assets (TTM)

CMPX0.0%

CNTN0.0%

Interest Coverage (TTM)

CMPXN/A

CNTNN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

CNTN0.00x

Beta

CMPX1.07

CNTN1.52

52W Performance

CMPX-74.5%

CNTN-33.6%

YTD Performance

CMPX-80.8%

CNTN-37.6%

% from 52W High

CMPX-85.6%

CNTN-69.4%

% from 52W Low

CMPX19.7%

CNTN20.6%

Asset Turnover (TTM)

CMPX0.00x

CNTN0.00x

FCF Yield (TTM)

CMPX-31.5%

CNTN-97.9%

Earnings Yield (TTM)

CMPX-16.8%

CNTN-60.3%

Dividend Yield (TTM)

CMPXN/A

CNTNN/A

Rule of 40

CMPX0.0

CNTN-10,651.0

EV/GP/RG

CMPXN/A

CNTNN/A

Ticker research

View CMPX research View CNTN research

Metric	CMPX Compass Therapeutics Inc.	CNTN Canton Strategic Holdings Inc
Market & Valuation
Market Cap	$179M	$163M
Enterprise Value	$143M	$125M
Price	$0.99	$2.11
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	108.78x
EV/Sales	0.00x	83.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	0.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-0.79x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.5%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1120.1%
Net Margin (TTM)	0.0%	-6559.1%
FCF Margin (TTM)	N/A	-10651.0%
Net Income (TTM)	$-30M	$-98M
FCF (TTM)	$-56M	$-159M
EPS (TTM)	$0.00	-$0.45
ROE (TTM)	-2994.0%	-2954.0%
ROA (TTM)	-2635.0%	-2342.0%
ROIC (TTM)	-2994.0%	-2953.0%
Financial Health
Cash	$35M	$37M
Debt	$0	$0
Net Cash/Debt	$35M	$37M
Current Ratio (TTM)	11.22x	15.70x
Quick Ratio (TTM)	11.15x	14.45x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.52
52W Performance	-74.5%	-33.6%
YTD Performance	-80.8%	-37.6%
% from 52W High	-85.6%	-69.4%
% from 52W Low	19.7%	20.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.5%	-97.9%
Earnings Yield (TTM)	-16.8%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-10,651.0
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View CNTN research